News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
148,022 Results
Type
Article (16726)
Company Profile (52)
Press Release (131239)
Multimedia
Podcasts (53)
Webinars (7)
Section
Business (39029)
Career Advice (1720)
Deals (6042)
Drug Delivery (80)
Drug Development (19322)
Employer Resources (116)
FDA (4309)
Job Trends (3789)
News (71505)
Policy (9691)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (972)
Accelerated approval (23)
Adcomms (15)
Allergies (70)
Alliances (11903)
ALS (61)
Alzheimer's disease (536)
Antibody-drug conjugate (ADC) (142)
Approvals (4253)
Artificial intelligence (216)
Autoimmune disease (63)
Automation (13)
Bankruptcy (63)
Best Places to Work (2978)
BIOSECURE Act (21)
Biosimilars (154)
Biotechnology (35)
Bladder cancer (49)
Brain cancer (23)
Breast cancer (187)
Cancer (1389)
Cardiovascular disease (86)
Career advice (1431)
Career pathing (34)
CAR-T (78)
CDC (29)
Cell therapy (245)
Cervical cancer (13)
Clinical research (16297)
Collaboration (599)
Company closure (3)
Compensation (119)
Complete response letters (36)
COVID-19 (1116)
CRISPR (30)
C-suite (233)
Cystic fibrosis (31)
Data (1815)
Decentralized trials (1)
Denatured (13)
Depression (46)
Diabetes (156)
Diagnostics (1211)
Digital health (9)
Diversity (6)
Diversity, equity & inclusion (30)
Drug discovery (128)
Drug pricing (112)
Drug shortages (13)
Duchenne muscular dystrophy (100)
Earnings (13289)
Editorial (61)
Employer branding (13)
Employer resources (107)
Events (17810)
Executive appointments (230)
FDA (5355)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (10)
Funding (454)
Gene editing (76)
Generative AI (29)
Gene therapy (269)
GLP-1 (376)
Government (2183)
Grass and pollen (2)
Guidances (96)
Healthcare (4074)
HIV (29)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (129)
Immuno-oncology (36)
Indications (33)
Infectious disease (1228)
Inflammatory bowel disease (75)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (52)
Interviews (324)
IPO (2500)
IRA (35)
Job creations (851)
Job search strategy (1170)
JPM (40)
Kidney cancer (4)
Labor market (58)
Layoffs (204)
Leadership (32)
Legal (2040)
Liver cancer (21)
Longevity (11)
Lung cancer (201)
Lymphoma (85)
Machine learning (24)
Management (43)
Manufacturing (409)
MASH (44)
Medical device (2348)
Medtech (2363)
Mergers & acquisitions (3798)
Metabolic disorders (459)
Multiple sclerosis (53)
NASH (5)
Neurodegenerative disease (118)
Neuropsychiatric disorders (32)
Neuroscience (926)
NextGen: Class of 2026 (1708)
Non-profit (1242)
Now hiring (24)
Obesity (237)
Opinion (250)
Ovarian cancer (47)
Pain (51)
Pancreatic cancer (53)
Parkinson's disease (69)
Partnered (21)
Patents (107)
Patient recruitment (123)
Peanut (29)
People (11763)
Pharmaceutical (12)
Pharmacy benefit managers (15)
Phase 1 (5210)
Phase 2 (6801)
Phase 3 (5987)
Pipeline (1698)
Policy (228)
Postmarket research (477)
Preclinical (2066)
Press Release (66)
Prostate cancer (61)
Psychedelics (26)
Radiopharmaceuticals (65)
Rare diseases (350)
Real estate (1544)
Recruiting (51)
Regulatory (7296)
Reports (16)
Research institute (791)
Resumes & cover letters (292)
Rett syndrome (11)
RNA editing (8)
RSV (27)
Schizophrenia (43)
Series A (76)
Series B (53)
Service/supplier (3)
Sickle cell disease (36)
Special edition (12)
Spinal muscular atrophy (38)
Sponsored (26)
Startups (971)
State (1)
Stomach cancer (8)
Supply chain (35)
Tariffs (56)
The Weekly (40)
Vaccines (511)
Venture capital (51)
Weight loss (182)
Women's health (28)
Worklife (17)
Date
Today (12)
Last 7 days (152)
Last 30 days (600)
Last 365 days (8271)
2026 (1027)
2025 (8281)
2024 (8788)
2023 (9237)
2022 (11925)
2021 (13039)
2020 (12092)
2019 (10750)
2018 (8462)
2017 (7694)
2016 (7503)
2015 (8368)
2014 (5839)
2013 (4534)
2012 (4943)
2011 (5134)
2010 (3846)
Location
Africa (376)
Alabama (23)
Alaska (2)
Arizona (33)
Arkansas (4)
Asia (10252)
Australia (1706)
California (2809)
Canada (606)
China (436)
Colorado (85)
Connecticut (98)
Delaware (118)
Europe (21756)
Florida (394)
Georgia (53)
Hawaii (1)
Idaho (19)
Illinois (167)
India (37)
Indiana (93)
Iowa (10)
Japan (117)
Kansas (28)
Kentucky (18)
Louisiana (7)
Maine (11)
Maryland (536)
Massachusetts (2046)
Michigan (56)
Minnesota (107)
Mississippi (5)
Missouri (32)
Montana (10)
Nebraska (2)
Nevada (18)
New Hampshire (13)
New Jersey (882)
New Mexico (7)
New York (826)
North Carolina (370)
North Dakota (9)
Northern California (1303)
Ohio (96)
Oklahoma (12)
Oregon (10)
Pennsylvania (415)
Puerto Rico (3)
Rhode Island (12)
South America (442)
South Carolina (13)
Southern California (1166)
Tennessee (22)
Texas (444)
United States (9863)
Utah (68)
Virginia (49)
Washington D.C. (26)
Washington State (207)
West Virginia (2)
Wisconsin (28)
148,022 Results for "just evotec biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evotec Closes Sale of Just - Evotec Biologics’ Toulouse Site to Sandoz
December 8, 2025
·
5 min read
Press Releases
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
January 8, 2026
·
5 min read
Press Releases
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site
July 30, 2025
·
1 min read
Press Releases
Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site
July 30, 2025
·
6 min read
Press Releases
Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
July 30, 2025
·
4 min read
Policy
Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
Evotec SE announced that its Seattle-based subsidiary, Just - Evotec Biologics, Inc., was selected by the U.S. Department of Defense to develop an accelerated monoclonal antibody development and manufacturing solution for the DOD’s Manufacturing Optimization Program.
June 25, 2024
·
7 min read
Press Releases
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
January 5, 2026
·
3 min read
Press Releases
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
December 4, 2025
·
6 min read
Press Releases
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
October 27, 2025
·
3 min read
FDA
Moderna’s Outright Flu Refusal Just the Latest Case of Crossed FDA Signals
The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is part of a larger communications crisis unfolding at the agency over the past nine months that has also ensnarled Sarepta, Capricor, uniQure and many more.
February 13, 2026
·
6 min read
·
Heather McKenzie
1 of 14,803
Next
